Literature DB >> 2339415

Time course of inhibition of acetylcholinesterase and aliesterases following parathion and paraoxon exposures in rats.

J E Chambers1, H W Chambers.   

Abstract

The inhibition of cerebral cortex and medulla oblongata acetylcholinesterase and hepatic and plasma aliesterases was studied in female rats following intraperitoneal administration of the phosphorothionate insecticide parathion or its active metabolite paraoxon. Acetylcholinesterase is the target enzyme for organophosphate toxicity while aliesterases are alternative targets for organophosphate inhibition which could serve in a protective capacity during organophosphate intoxication. The effects of pretreatment with cytochrome P450 inducers and inhibitors were also investigated. Pretreatment with phenobarbital slowed the time course of acetylcholinesterase and hepatic aliesterase inhibition following parathion exposure, suggesting the induction of a detoxication pathway(s) to a greater extent than the induction of activation. Although pretreatment with piperonyl butoxide did not affect the rate of acetylcholinesterase inhibition, it slowed hepatic and plasma aliesterase inhibition following parathion administration, presumably from inhibition of the parathion activation pathway. In rats pretreated with beta-naphthoflavone (BNF), hepatic aliesterases demonstrated lower specific activity; additionally, there was a reduced level of inhibition in BNF-pretreated rats following either parathion or paraoxon administration. However, any effects of BNF on parathion- or paraoxon-induced inhibition cannot be distinguished at this time from the effects of the oil vehicle, which reduced esterase inhibition, presumably by its ability to sequester the organophosphate. Brain acetylcholinesterase was partially inhibited before the hepatic aliesterases were maximally inhibited in all treatment groups. In most cases, plasma aliesterases were maximally inhibited within 15 min after organophosphate administration. Thus hepatic aliesterases constitute an important but not completely effective form of protection from the inhibitory effects of organophosphates.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2339415     DOI: 10.1016/0041-008x(90)90315-l

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  7 in total

1.  Relationship of human paraoxonase-1 serum activity and genotype with atherosclerosis in individuals from the Deep South.

Authors:  R Hunter Coombes; J Allen Crow; MaryBeth Dail; Howard W Chambers; Robert W Wills; Janice E Chambers
Journal:  Pharmacogenet Genomics       Date:  2011-12       Impact factor: 2.089

2.  Characterization of carboxylesterase in skin mucus of Cirrhinus mrigala and its assessment as biomarker of organophosphate exposure.

Authors:  Ashwini Kumar Nigam; Usha Kumari; Swati Mittal; Ajay Kumar Mittal
Journal:  Fish Physiol Biochem       Date:  2013-10-05       Impact factor: 2.794

Review 3.  Novel approaches to mitigating parathion toxicity: targeting cytochrome P450-mediated metabolism with menadione.

Authors:  Yi-Hua Jan; Jason R Richardson; Angela A Baker; Vladimir Mishin; Diane E Heck; Debra L Laskin; Jeffrey D Laskin
Journal:  Ann N Y Acad Sci       Date:  2016-07-21       Impact factor: 5.691

4.  Inhibition of carboxylesterase 1 is associated with cholesteryl ester retention in human THP-1 monocyte/macrophages.

Authors:  J Allen Crow; Brandy L Middleton; Abdolsamad Borazjani; M Jason Hatfield; Philip M Potter; Matthew K Ross
Journal:  Biochim Biophys Acta       Date:  2008-08-05

5.  Vitamin K3 (menadione) redox cycling inhibits cytochrome P450-mediated metabolism and inhibits parathion intoxication.

Authors:  Yi-Hua Jan; Jason R Richardson; Angela A Baker; Vladimir Mishin; Diane E Heck; Debra L Laskin; Jeffrey D Laskin
Journal:  Toxicol Appl Pharmacol       Date:  2015-07-23       Impact factor: 4.219

6.  In vitro age-related differences in rats to organophosphates.

Authors:  Edward C Meek; Russell L Carr; Janice E Chambers
Journal:  Toxicol In Vitro       Date:  2021-01-23       Impact factor: 3.500

Review 7.  Pharmacokinetics and molecular detoxication.

Authors:  J R Cashman; B Y Perotti; C E Berkman; J Lin
Journal:  Environ Health Perspect       Date:  1996-03       Impact factor: 9.031

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.